Clinical Trial Update: Genomic and Psychosocial Effects of the 3RP on Patients With MGUS and Smoldering Multiple Myeloma [NA]

View source ↗

Summary

ClinicalTrials.gov entry noting the completed study evaluating genomic and psychosocial effects of the 3RP in patients with Monoclonal Gammopathy of Undetermine…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Monoclonal Gammopathy of Undetermined Significance
• Smoldering Multiple Myeloma

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma | NA | Status: COMPLETED